vs

Side-by-side financial comparison of HCW Biologics Inc. (HCWB) and Quantum Computing Inc. (QUBT). Click either name above to swap in a different company.

HCW Biologics Inc. is the larger business by last-quarter revenue ($394.8K vs $198.0K, roughly 2.0× Quantum Computing Inc.). Quantum Computing Inc. runs the higher net margin — -785.9% vs -854.4%, a 68.6% gap on every dollar of revenue. On growth, Quantum Computing Inc. posted the faster year-over-year revenue change (219.4% vs -70.2%). HCW Biologics Inc. produced more free cash flow last quarter ($-2.9M vs $-12.2M). Over the past eight quarters, Quantum Computing Inc.'s revenue compounded faster (99.0% CAGR vs -45.8%).

HCW Biologics Inc. is a clinical-stage biotechnology company focused on researching and developing novel immunotherapies and biological products targeting unmet medical needs in oncology, chronic inflammatory disorders, and autoimmune diseases. It primarily operates in the U.S., advancing multiple pipeline candidates through early to mid-stage clinical trials.

Rigetti Computing, Inc. is a Berkeley, California-based developer of superconducting quantum integrated circuits used for quantum computers. Rigetti also develops a cloud platform called Forest that enables programmers to write quantum algorithms.

HCWB vs QUBT — Head-to-Head

Bigger by revenue
HCWB
HCWB
2.0× larger
HCWB
$394.8K
$198.0K
QUBT
Growing faster (revenue YoY)
QUBT
QUBT
+289.5% gap
QUBT
219.4%
-70.2%
HCWB
Higher net margin
QUBT
QUBT
68.6% more per $
QUBT
-785.9%
-854.4%
HCWB
More free cash flow
HCWB
HCWB
$9.2M more FCF
HCWB
$-2.9M
$-12.2M
QUBT
Faster 2-yr revenue CAGR
QUBT
QUBT
Annualised
QUBT
99.0%
-45.8%
HCWB

Income Statement — Q4 FY2024 vs Q4 FY2025

Metric
HCWB
HCWB
QUBT
QUBT
Revenue
$394.8K
$198.0K
Net Profit
$-3.4M
$-1.6M
Gross Margin
20.0%
-49.5%
Operating Margin
-795.9%
-11220.2%
Net Margin
-854.4%
-785.9%
Revenue YoY
-70.2%
219.4%
Net Profit YoY
68.4%
97.0%
EPS (diluted)
$-10.47
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HCWB
HCWB
QUBT
QUBT
Q4 25
$198.0K
Q3 25
$384.0K
Q2 25
$61.0K
Q4 24
$394.8K
$62.0K
Q3 24
$426.4K
$101.0K
Q2 24
$618.9K
$183.0K
Q1 24
$1.1M
Q4 23
$1.3M
$75.0K
Net Profit
HCWB
HCWB
QUBT
QUBT
Q4 25
$-1.6M
Q3 25
$2.4M
Q2 25
$-36.5M
Q4 24
$-3.4M
$-51.2M
Q3 24
$-3.9M
$-5.7M
Q2 24
$-15.3M
$-5.2M
Q1 24
$-7.5M
Q4 23
$-10.7M
$-6.6M
Gross Margin
HCWB
HCWB
QUBT
QUBT
Q4 25
-49.5%
Q3 25
32.8%
Q2 25
42.6%
Q4 24
20.0%
54.8%
Q3 24
20.0%
8.9%
Q2 24
29.2%
31.7%
Q1 24
54.6%
Q4 23
19.1%
13.3%
Operating Margin
HCWB
HCWB
QUBT
QUBT
Q4 25
-11220.2%
Q3 25
-2709.4%
Q2 25
-16673.8%
Q4 24
-795.9%
-14375.8%
Q3 24
-864.1%
-5384.2%
Q2 24
-2445.8%
-2878.1%
Q1 24
-665.1%
Q4 23
-813.3%
-8772.0%
Net Margin
HCWB
HCWB
QUBT
QUBT
Q4 25
-785.9%
Q3 25
620.3%
Q2 25
-59806.6%
Q4 24
-854.4%
-82640.3%
Q3 24
-915.1%
-5618.8%
Q2 24
-2469.1%
-2838.3%
Q1 24
-662.8%
Q4 23
-806.7%
-8836.0%
EPS (diluted)
HCWB
HCWB
QUBT
QUBT
Q4 25
$0.03
Q3 25
$0.01
Q2 25
$-0.26
Q4 24
$-10.47
$-0.53
Q3 24
$-4.13
$-0.06
Q2 24
$-16.16
$-0.06
Q1 24
$-0.20
Q4 23
$-0.30
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HCWB
HCWB
QUBT
QUBT
Cash + ST InvestmentsLiquidity on hand
$4.7M
$1.1B
Total DebtLower is stronger
$7.4M
Stockholders' EquityBook value
$-6.8M
$1.6B
Total Assets
$30.2M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HCWB
HCWB
QUBT
QUBT
Q4 25
$1.1B
Q3 25
$555.6M
Q2 25
$348.8M
Q4 24
$4.7M
$78.9M
Q3 24
$998.2K
$3.1M
Q2 24
$1.2M
$2.5M
Q1 24
$4.1M
Q4 23
$3.6M
$2.1M
Total Debt
HCWB
HCWB
QUBT
QUBT
Q4 25
Q3 25
Q2 25
Q4 24
$7.4M
Q3 24
$6.5M
Q2 24
$9.9M
Q1 24
$8.3M
Q4 23
$6.3M
Stockholders' Equity
HCWB
HCWB
QUBT
QUBT
Q4 25
$1.6B
Q3 25
$877.9M
Q2 25
$396.0M
Q4 24
$-6.8M
$107.3M
Q3 24
$-10.0M
$60.4M
Q2 24
$-6.3M
$65.5M
Q1 24
$8.7M
Q4 23
$13.5M
$68.7M
Total Assets
HCWB
HCWB
QUBT
QUBT
Q4 25
$1.6B
Q3 25
$898.2M
Q2 25
$426.1M
Q4 24
$30.2M
$153.6M
Q3 24
$26.6M
$76.8M
Q2 24
$26.8M
$76.0M
Q1 24
$30.4M
Q4 23
$28.5M
$74.4M
Debt / Equity
HCWB
HCWB
QUBT
QUBT
Q4 25
Q3 25
Q2 25
Q4 24
Q3 24
Q2 24
Q1 24
0.95×
Q4 23
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HCWB
HCWB
QUBT
QUBT
Operating Cash FlowLast quarter
$-2.8M
$-11.0M
Free Cash FlowOCF − Capex
$-2.9M
$-12.2M
FCF MarginFCF / Revenue
-746.8%
-6147.5%
Capex IntensityCapex / Revenue
28.7%
583.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.5M
$-37.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HCWB
HCWB
QUBT
QUBT
Q4 25
$-11.0M
Q3 25
$-8.7M
Q2 25
$-6.1M
Q4 24
$-2.8M
$-3.8M
Q3 24
$-2.9M
$-4.6M
Q2 24
$-4.9M
$-4.0M
Q1 24
$-3.6M
Q4 23
$-3.9M
$-5.0M
Free Cash Flow
HCWB
HCWB
QUBT
QUBT
Q4 25
$-12.2M
Q3 25
$-11.5M
Q2 25
$-7.1M
Q4 24
$-2.9M
$-6.6M
Q3 24
$-3.0M
$-5.1M
Q2 24
$-4.9M
$-5.1M
Q1 24
$-3.7M
Q4 23
$-7.6M
$-5.0M
FCF Margin
HCWB
HCWB
QUBT
QUBT
Q4 25
-6147.5%
Q3 25
-3000.3%
Q2 25
-11683.6%
Q4 24
-746.8%
-10709.7%
Q3 24
-695.0%
-5040.6%
Q2 24
-788.7%
-2782.0%
Q1 24
-331.4%
Q4 23
-574.8%
-6693.3%
Capex Intensity
HCWB
HCWB
QUBT
QUBT
Q4 25
583.8%
Q3 25
723.2%
Q2 25
1678.7%
Q4 24
28.7%
4622.6%
Q3 24
8.7%
508.9%
Q2 24
3.0%
588.5%
Q1 24
11.5%
Q4 23
280.6%
70.7%
Cash Conversion
HCWB
HCWB
QUBT
QUBT
Q4 25
Q3 25
-3.67×
Q2 25
Q4 24
Q3 24
Q2 24
Q1 24
Q4 23

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons